SCHEMBL13739371

SCHEMBL13739371

CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)NCCNC(=O)O

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR1 P21554 7/20 0.73
▸ ALDH1A1 P00352 5/20 0.73
▸ FAAH O00519 2/20 0.69
▸ CNR2 P34972 3/20 0.58
▸ MAPT P10636 3/20 0.58
▸ CYP19A1 P11511 2/20 0.58
▸ RXRA P19793 2/20 0.58
▸ PPARG P37231 2/20 0.58
▸ OXER1 Q8TDS5 2/20 0.58
▸ FFAR1 O14842 1/20 0.58
▸ ALOX12 P18054 1/20 0.56
▸ EPHX2 P34913 3/20 0.52
▸ KMT2A Q03164 2/20 0.50
▸ F7 P08709 1/20 0.50
▸ ADORA3 P0DMS8 1/20 0.50
▸ F3 P13726 1/20 0.50
▸ PTGS1 P23219 1/20 0.50
▸ PPARD Q03181 1/20 0.50
▸ PPARA Q07869 1/20 0.50
▸ MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2405799 1.00 CNR1 (0.73) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL12319236 0.93 CNR1 (0.83) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL15253154 0.90 CNR1 (0.75) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL15253153 0.90 CNR1 (0.75) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL15253026 0.90 CNR1 (0.64) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL15253025 0.90 CNR1 (0.64) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL14739939 0.90 CNR1 (0.64) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL14739941 0.90 CNR1 (0.64) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL18076224 0.88 CNR1 (0.62) CNR1ALDH1A1FAAHCNR2MAPT
SCHEMBL18076225 0.88 CNR1 (0.62) CNR1ALDH1A1FAAHCNR2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140288025-A1 FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2014-09-25 — — US disclosed
US-20130244966-A1 FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2013-09-19 — — US disclosed
WO-2013090420-A2 FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2013-06-20 — — WO disclosed
WO-2012154564-A1 FATTY ACID PHENOLIC DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2012-11-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130244966-A1 FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES FABP1, FABP2, HAVCR2 CNR1 2600/4885ALDH1A1 1235/4885FAAH 81/4885
US-20140288025-A1 FATTY ACID ANTIVIRAL CONJUGATES AND THEIR USES FABP1, FABP2, HAVCR2 CNR1 2600/4885ALDH1A1 1235/4885FAAH 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback